Innovations in Synthetic Biology and Sequencing Technology

Share this:
Published: 6 Apr 2018

This edition of the Genetic Technology TOE depicts life sciences trends across synthetic biology and sequencing technology. Engineered chimeric molecules and promoters, nanobody platforms, next-generation RNA sequencing technologies coupled with machine learning systems, are some of the most relevant innovations profiled. Vector delivery platform technologies expected to undergo clinical studies in the coming quarter are also depicted. The Genetic Technology TechVision Opportunity Engine (TOE) presents the latest R&D developments and advances with an emphasis on opportunities to profit in the explosive field of genetic technology through technology transfer, joint ventures, and acquisitions. The complete gamut of genetic technology applications is covered including the latest developments in omics technologies; genetic, cellular, and alternative therapies; sequencing technologies; and genetically altered animals and plants. The Health & Wellness cluster tracks developments in a myriad of areas including genetic engineering, regenerative medicine, drug discovery and development, nanomedicine, nutrition, cosmetic procedures, pain and disease management and therapies, drug delivery, personalized medicine, and smart healthcare. Keywords: Engineered chimeric molecule, next-gen RNA sequencing, machine learning, engineered promoters, gene expression, nanobody, immunotherapy, vector delivery platform


Features of this research


Help Desk

Full list of offices

For more information and general enquiries, contact Frost & Sullivan near you.

North America
tel: +1.877.463.7678

Select a location near you..